Journal of Thoracic Oncology最新文献

筛选
英文 中文
Lung Cancer in Mozambique.
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 DOI: 10.1016/j.jtho.2024.08.013
Assucena Guisseve, Albertino Mualinque, Matchecane Cossa, Ariel Durañones Jerez, Satish Tulsidás, Vania Cabrá, Edília Botão, Narciso Sitoe, Adriano Tivane, Anilsa Daniel, Alberto Gudo Morais, Atílio Morais, Fabíola Fernandes, Cesaltina Lorenzoni, Fátima Carneiro, Elizabete Nunes, Rita Barros, Carla Carrilho
{"title":"Lung Cancer in Mozambique.","authors":"Assucena Guisseve, Albertino Mualinque, Matchecane Cossa, Ariel Durañones Jerez, Satish Tulsidás, Vania Cabrá, Edília Botão, Narciso Sitoe, Adriano Tivane, Anilsa Daniel, Alberto Gudo Morais, Atílio Morais, Fabíola Fernandes, Cesaltina Lorenzoni, Fátima Carneiro, Elizabete Nunes, Rita Barros, Carla Carrilho","doi":"10.1016/j.jtho.2024.08.013","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.08.013","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 12","pages":"1599-1605"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why and When Do We Invasively Restage After Neoadjuvant Chemoimmunotherapy?
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 DOI: 10.1016/j.jtho.2024.09.1436
Jonathan D Spicer, Tina Cascone, Murry W Wynes, Karen L Kelly
{"title":"Why and When Do We Invasively Restage After Neoadjuvant Chemoimmunotherapy?","authors":"Jonathan D Spicer, Tina Cascone, Murry W Wynes, Karen L Kelly","doi":"10.1016/j.jtho.2024.09.1436","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.09.1436","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 12","pages":"e98-e99"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium Society. 美国镭学会® (ARS) 中心/超中心位置非小细胞肺癌适当使用标准 (AUC) 执行摘要:系统回顾与指南》。
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 Epub Date: 2024-09-11 DOI: 10.1016/j.jtho.2024.09.1386
Henry S Park, Andreas Rimner, Arya Amini, Joe Y Chang, Stephen G Chun, Jessica Donington, Martin J Edelman, Matthew A Gubens, Kristin A Higgins, Puneeth Iyengar, Aditya Juloori, Benjamin Movsas, Zsuzsanna Nemeth, Matthew S Ning, George Rodrigues, Andrea Wolf, Charles B Simone
{"title":"Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium Society.","authors":"Henry S Park, Andreas Rimner, Arya Amini, Joe Y Chang, Stephen G Chun, Jessica Donington, Martin J Edelman, Matthew A Gubens, Kristin A Higgins, Puneeth Iyengar, Aditya Juloori, Benjamin Movsas, Zsuzsanna Nemeth, Matthew S Ning, George Rodrigues, Andrea Wolf, Charles B Simone","doi":"10.1016/j.jtho.2024.09.1386","DOIUrl":"10.1016/j.jtho.2024.09.1386","url":null,"abstract":"<p><strong>Introduction: </strong>Definitive radiation therapy is considered standard therapy for medically inoperable early-stage NSCLC. Nevertheless, for patients with tumors located near structures such as the proximal tracheobronchial tree, esophagus, heart, spinal cord, and brachial plexus, the optimal management regimen is controversial. The objective was to develop expert multidisciplinary consensus guidelines on managing medically inoperable NSCLC located in a central or ultracentral location relative to critical organs at risk.</p><p><strong>Methods: </strong>Case variants regarding centrally and ultracentrally located lung tumors were developed by the 15-member multidisciplinary American Radium Society (ARS) Thoracic Appropriate Use Criteria (AUC) expert panel. A comprehensive review of the English medical literature was performed from January 1 1946 to December 31 2023 to inform consensus guidelines. Modified Delphi methods were used by the panel to evaluate the variants and procedures, with at least three rating points from median defining agreement/consensus. The guideline was then approved by the ARS Executive Committee and released for public comment per established ARS procedures.</p><p><strong>Results: </strong>The Thoracic ARS AUC Panel identified 90 relevant references and obtained consensus in all variants. Radiotherapy alone was considered appropriate, with additional immunotherapy to be considered primarily in the clinical trial setting. Hypofractionated radiotherapy in eight to 18 fractions was considered appropriate for ultracentral lesions near the proximal tracheobronchial tree, upper trachea, and esophagus. For other ultracentral lesions near the heart, great vessels, brachial plexus, and spine, or for non-ultracentral but still central lesions, five-fraction stereotactic body radiation therapy was also considered an appropriate option. Intensity-modulated radiotherapy was considered appropriate and three-dimensional-conformal radiotherapy inappropriate for all variants. Other treatment planning techniques to decrease the risk of overdosing critical organs at risk were also considered.</p><p><strong>Conclusions: </strong>The ARS Thoracic AUC panel has developed multidisciplinary consensus guidelines for various presentations of stage I NSCLC in a central or ultracentral location.</p>","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":" ","pages":"1640-1653"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142290061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defining the Pathway to Precision Therapies for Squamous Lung Cancers.
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 DOI: 10.1016/j.jtho.2024.09.1423
Malinda Itchins, Aaron C Tan
{"title":"Defining the Pathway to Precision Therapies for Squamous Lung Cancers.","authors":"Malinda Itchins, Aaron C Tan","doi":"10.1016/j.jtho.2024.09.1423","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.09.1423","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 12","pages":"1591-1593"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to the Letter to the Editor: The Relationship Between Air Pollution and Lung Cancer: Differences in Sensitivity Across Regions and Populations.
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 DOI: 10.1016/j.jtho.2024.09.1380
Run-Xuan Zhou, Da-Wei Ye
{"title":"Reply to the Letter to the Editor: The Relationship Between Air Pollution and Lung Cancer: Differences in Sensitivity Across Regions and Populations.","authors":"Run-Xuan Zhou, Da-Wei Ye","doi":"10.1016/j.jtho.2024.09.1380","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.09.1380","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 12","pages":"e82-e84"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the International Association for the Study of Lung Cancer Early Detection and Screening Committee: Terminology Issues in Screening and Early Detection of Lung Cancer-International Association for the Study of Lung Cancer Early Detection and Screening Committee Expert Group Recommendations. 摘自 IASLC 早期检测和筛查委员会肺癌筛查和早期检测术语问题 - IASLC 早期检测和筛查委员会专家组建议。
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 Epub Date: 2024-08-02 DOI: 10.1016/j.jtho.2024.07.022
Rudolf M Huber, Milena Cavic, Haval Balata, Andrea Borondy Kitts, John K Field, Claudia Henschke, Ella A Kazerooni, Anna Kerpel-Fronius, Robert A Smith, Emanuela Taioli, Luigi Ventura, Stephen Lam, David Yankelevitz, Martin Tammemägi
{"title":"From the International Association for the Study of Lung Cancer Early Detection and Screening Committee: Terminology Issues in Screening and Early Detection of Lung Cancer-International Association for the Study of Lung Cancer Early Detection and Screening Committee Expert Group Recommendations.","authors":"Rudolf M Huber, Milena Cavic, Haval Balata, Andrea Borondy Kitts, John K Field, Claudia Henschke, Ella A Kazerooni, Anna Kerpel-Fronius, Robert A Smith, Emanuela Taioli, Luigi Ventura, Stephen Lam, David Yankelevitz, Martin Tammemägi","doi":"10.1016/j.jtho.2024.07.022","DOIUrl":"10.1016/j.jtho.2024.07.022","url":null,"abstract":"<p><strong>Introduction: </strong>To facilitate global implementation of lung cancer (LC) screening and early detection in a quality assured and consistent manner, common terminology is needed. Researchers and clinicians within different specialties may use the same terms but with different meanings or different terms for the same intended meanings.</p><p><strong>Methods: </strong>The Diagnostics Working Group of the International Association for the Study of Lung Cancer Early Detection and Screening Committee has analyzed and discussed relevant terms used on a regular basis and suggests recommendations for consensus definitions of terminology applicable in this setting. We explored how to reach consensus to define relevant and unambiguous terminology for use by health care providers, researchers, patients, screening participants, and family.</p><p><strong>Results: </strong>Terms and definitions for epidemiologic and health-economical purposes included the following: standardized incidence and mortality rates, LC-specific survival, long-term survival and cure rates, overdiagnosis, overtreatment, and undertreatment. Terms and definitions for defining screening findings included the following: positive, false-positive, negative, false-negative, and indeterminate findings and additional and incidental findings. Terms and definitions for describing parameters in screening programs included the following: opportunistic versus programmatic screening, screening rounds, interval or interim diagnoses, and invasive and minimally invasive procedures. Terms and definitions for shared decision-making included the following: LC screening-possible harms and risks and LC risk and modifiers prior and posterior to a measure.</p><p><strong>Conclusions: </strong>A common set of terminology with standard definitions is recommended for describing clinical LC screening programs, the discussion about effectiveness and outcomes, or the clinical setting. The use of the terms should be clearly defined and explained.</p>","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":" ","pages":"1606-1617"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141889650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on "Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable NSCLC".
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 DOI: 10.1016/j.jtho.2024.07.026
Dongzhi Jiang, Fei Yang, Huiwei Deng
{"title":"Commentary on \"Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable NSCLC\".","authors":"Dongzhi Jiang, Fei Yang, Huiwei Deng","doi":"10.1016/j.jtho.2024.07.026","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.07.026","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 12","pages":"e79-e80"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy. 美国镭学会™ 《胸部放疗后心脏毒性预防和处理的适当使用标准》(American Radium Society™ Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy)。
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 Epub Date: 2024-09-21 DOI: 10.1016/j.jtho.2024.09.1433
Arya Amini, Vlad G Zaha, Eman Hamad, Pamela K Woodard, Andreas Rimner, Joe Y Chang, Stephen G Chun, Jessica Donington, Martin J Edelman, Matthew A Gubens, Kristin A Higgins, Puneeth Iyengar, Aditya Juloori, Benjamin Movsas, Matthew S Ning, Henry S Park, George Rodrigues, Andrea Wolf, Charles B Simone
{"title":"American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy.","authors":"Arya Amini, Vlad G Zaha, Eman Hamad, Pamela K Woodard, Andreas Rimner, Joe Y Chang, Stephen G Chun, Jessica Donington, Martin J Edelman, Matthew A Gubens, Kristin A Higgins, Puneeth Iyengar, Aditya Juloori, Benjamin Movsas, Matthew S Ning, Henry S Park, George Rodrigues, Andrea Wolf, Charles B Simone","doi":"10.1016/j.jtho.2024.09.1433","DOIUrl":"10.1016/j.jtho.2024.09.1433","url":null,"abstract":"<p><strong>Introduction: </strong>The multidisciplinary American Radium Society Thoracic Committee was assigned to create appropriate use criteria on cardiac toxicity prevention and management for patients undergoing radiotherapy.</p><p><strong>Methods: </strong>A systematic review of the current literature was conducted. Case variants of patients with thoracic malignancies undergoing radiation were created based on presence or absence of cardiovascular risk factors and treatment-related risks assessed by dose exposure to the heart and cardiac substructures. Modified Delphi methodology was used to evaluate the variants and procedures, with less than or equal to three rating points from median defining agreement/consensus.</p><p><strong>Results: </strong>A total of six variants were evaluated. The panel felt that patients with cardiac comorbidities at high risk for radiation-related cardiac toxicity should undergo a prescreening cardiac-focused history and physical (H&P) examination, electrocardiogram, cardiac imaging including an echocardiogram, and referral to a cardiologist/cardio-oncologist. Recommendations for those without cardiac comorbidities at low risk for cardiac toxicity were to undergo a baseline H&P examination only. Conversely, those without cardiac comorbidities but at high risk for radiation-related cardiac toxicity were recommended to undergo a prescreening electrocardiogram, in addition to a H&P examination. For patients with cardiac comorbidities at low risk for cardiac toxicity, the panel felt that prescreening and postscreening tests may be appropriate.</p><p><strong>Conclusions: </strong>The American Radium Society Thoracic appropriate use criteria panel has developed multidisciplinary consensus guidelines for cardiac toxicity prevention, surveillance, and management after thoracic radiotherapy based on cardiac comorbidities at presentation and risk of radiation-related cardiac toxicity.</p>","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":" ","pages":"1654-1667"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142308050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening the Evidence: Expanding Research on Passive Smoking and Lung Cancer.
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 DOI: 10.1016/j.jtho.2024.08.027
Xinyu Xu, Jiebin Xie, Zining Luo
{"title":"Strengthening the Evidence: Expanding Research on Passive Smoking and Lung Cancer.","authors":"Xinyu Xu, Jiebin Xie, Zining Luo","doi":"10.1016/j.jtho.2024.08.027","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.08.027","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 12","pages":"e94-e95"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor-Naïve Circulating Tumor DNA Detection Will Potentially Overturn the Strategy of Care in Early-Stage NSCLC.
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-12-01 DOI: 10.1016/j.jtho.2024.08.008
Filippo Lococo, Marco Chiappetta, Angelo Minucci, Emilio Bria, Stefano Margaritora
{"title":"Tumor-Naïve Circulating Tumor DNA Detection Will Potentially Overturn the Strategy of Care in Early-Stage NSCLC.","authors":"Filippo Lococo, Marco Chiappetta, Angelo Minucci, Emilio Bria, Stefano Margaritora","doi":"10.1016/j.jtho.2024.08.008","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.08.008","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 12","pages":"e84-e85"},"PeriodicalIF":21.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信